NCT05336136

Brief Summary

One significant challenge to non-invasive ventilation (NIV) use in children is finding masks to fit a wide range of growing shapes and sizes. While the technology has improved with development of masks specifically for children, the range of options remains limited. Given the smaller size relative to adults, craniofacial abnormalities and craniofacial differences are more likely to compromise mask fit for children. A poor mask fit is uncomfortable, alters delivery of airway pressure, and, in some children, leads to failure of NIV and the need for surgical insertion of an airway in the neck to deliver positive airway pressure through a tracheostomy. This makes expanding the technology to deliver NIV vital and custom NIV masks an exciting solution.In this study, this study will enroll children who are established on long-term NIV with at least some use within 3 months of starting this therapy but who have non-optimal adherence. After consenting to participate and completing demographic and health questionnaire, participants will undergo a facial scan using stereophotogrammetry. This scan will be imported into a computer-aided design software to create a NIV mask customized to the individual face. The steps of mask testing will include: i) Bench testing to compare the leak and comfort parameters of the current commercial mask used by the participant to the custom mask: ii) Efficacy of treatment as measured by polysomonography iii) NIV compliance from machine downloads; iv) Questionnaires to assess the subjective comfort, fit, and adverse events Finally, participants and their parents/guardian will be asked which mask they prefer and why.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
1mo left

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Dec 2023Jun 2026

First Submitted

Initial submission to the registry

June 7, 2021

Completed
11 months until next milestone

First Posted

Study publicly available on registry

April 20, 2022

Completed
1.7 years until next milestone

Study Start

First participant enrolled

December 15, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

2.5 years

First QC Date

June 7, 2021

Last Update Submit

March 13, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Change in apnea hypopnea index

    Polysomnography parameter - apnea hypopnea index

    Baseline (commercial mask study), repeated measure at 1 month (custom mask)

  • Change in obstructive apnea hypopnea index

    Polysomnography parameter - obstructive apnea hypopnea index

    Baseline (commercial mask study), repeated measure at 1 month (custom mask)

  • Change in oxygen desaturation index

    Polysomnography parameter - oxygen desaturation index

    Baseline (commercial mask study), repeated measure at 1 month (custom mask)

  • Change in percent time with oxygen saturation less than 90%

    Polysomnography parameter - percent time with oxygen saturation less than 90%

    Baseline (commercial mask study), repeated measure at 1 month (custom mask)

  • Change in percentage of nights used

    Machine download

    Two weeks of commercial versus custom mask use

  • Change in average time used/night

    Machine download

    Two weeks of commercial versus custom mask use

Secondary Outcomes (5)

  • Change in mask air leak (bench testing)

    Baseline (commercial mask study), repeated measure at 1 month (custom mask)

  • Change in mask comfort - participant (visual likert scale, 1-9)

    End of two week of mask use of commercial versus custom mask

  • Change in mask comfort - parent (visual likert scale1-9)

    End of two week of mask use of commercial versus custom mask

  • Mask preference - participant (question)

    End of trial - 1 month

  • Mask preference - parent (question)

    End of trial - 1 month

Study Arms (2)

Custom mask

EXPERIMENTAL

Custom mask based on 3D facial photograph for administration of non-invasive ventilation

Device: Custom mask

Current commercial mask

ACTIVE COMPARATOR

Current commercial mask used by the participant for administration of non-invasive ventilation

Device: Current commercial mask

Interventions

Custom mask based on 3D facial photograph for administration of non-invasive ventilation

Custom mask

Current commercial mask used for administration of non-invasive ventilation

Current commercial mask

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children between 8-12 years of age
  • Followed clinically by the Non-invasive ventilation clinic at the Stollery Children's Hospital
  • Established on non-invasive ventilation as part of their treatment plan.

You may not qualify if:

  • Children with developmental or physical disabilities that would prevent their successful completion of the study protocol (e.g., non-verbal, unable to follow 3-step commands, unalbe to lie still for 20 min).
  • Children whose parent/guardian are unable to provide consent because of an inability to read the study documents in english.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta

Edmonton, Alberta, T6G2R3, Canada

RECRUITING

MeSH Terms

Conditions

Patient Compliance

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Joanna E MacLean, MD, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Joanna E MacLean, MD, PhD

CONTACT

Pina Collarusso, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Within subject crossover
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2021

First Posted

April 20, 2022

Study Start

December 15, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations